New Wegovy Pill UK: Everything You Need to Know About the Latest Weight Loss Tablet
⭐ 4.9/5 on Google · GPhC Registered · NHS & Private · Same-day appointments in Kingston
⭐ 4.9/5 on Google · GPhC Registered · NHS & Private · Same-day appointments in Kingston
A guide to the newly approved Wegovy tablet, how it works, who it may be suitable for, and what it could mean for the future of weight loss treatment.
The Wegovy pill is the first GLP-1 weight loss medication available in tablet form to be approved in the UK. It contains semaglutide — the same active ingredient found in the Wegovy injection — and works by helping to reduce appetite, increase feelings of fullness, and lower food intake.
The Medicines and Healthcare products Regulatory Agency (MHRA) approved the Wegovy tablet in June 2026, making the UK one of the first countries to offer an oral GLP-1 treatment specifically for weight management. For many people, this represents an alternative way to access clinically proven weight loss treatment without using injections.
Weight loss medications have become one of the fastest-growing areas in healthcare. Demand for treatments such as Wegovy and Mounjaro has increased significantly over recent years as more people seek effective medical support for obesity and weight-related health conditions.
While injections have transformed treatment options, some patients remain hesitant about using needles — and others may simply prefer the convenience of a daily tablet. The arrival of the Wegovy pill provides another treatment choice, allowing patients and healthcare professionals to select the option that best fits an individual’s lifestyle and preferences.
The Wegovy tablet belongs to a group of medicines called GLP-1 receptor agonists. These medicines mimic a naturally occurring hormone that helps regulate appetite and food intake, meaning many people naturally eat less without feeling they are constantly dieting.
Like all licensed weight loss medications, the Wegovy pill is intended to be used alongside healthy lifestyle changes, including improvements in diet, physical activity and long-term behaviour change.
Eligibility criteria are expected to be similar to current Wegovy prescribing guidelines. Suitability is always assessed individually — factors such as your medical history, current medications, weight loss goals and previous treatment experience all influence which option may be most appropriate.
Clinical studies have shown impressive weight loss results with oral semaglutide. The best results are generally seen when medication is combined with long-term lifestyle support.
It is important to remember that individual results vary. Factors that influence weight loss include starting weight, medication adherence, diet, physical activity levels and underlying health conditions.
Both treatments contain semaglutide and work through the same biological pathway. The main differences are how they are taken and how they fit into your routine. The best option is often the one that fits your lifestyle and helps you remain consistent with treatment.
Healthcare professionals expect significant public interest in weight loss tablets once they become widely available. Importantly, the arrival of weight loss tablets does not replace injections — it expands the range of options available to patients.
One challenge with weight management is maintaining weight loss over the long term. Recent research has shown that oral weight loss medicines may play an important role in helping people maintain results after stopping injectable treatments.
Studies involving oral GLP-1 medications have demonstrated that patients switching from injections to tablets may retain a substantial proportion of their weight loss while continuing treatment. This supports the growing understanding that obesity is a chronic condition which often benefits from ongoing management rather than short-term intervention alone.
The approval of the Wegovy tablet marks an exciting development in weight management treatment. For many people, having a clinically proven tablet option may make treatment feel more accessible and convenient. However, choosing the right medication is only one part of a successful weight loss journey.
At The Kingston Pharmacy, our weight management service provides personalised support to help you understand your options and find the treatment that best suits your needs. Whether you are interested in Wegovy injections, Mounjaro or the newly approved Wegovy tablet, our team can help you make an informed decision and support you throughout your journey. The first step is to complete a consultation — we will review your medical history, discuss your goals, and recommend the most appropriate treatment plan for you.
Ready to get started with Weight Loss Treatment?
Complete a short consultation and our team will take care of the rest.
Start Consultation
A guide to the different medical weight loss treatments available, how they work, and how to choose
A practical guide to the safety of weight loss treatments, what side effects to expect, why they
A guide to your first few weeks on treatment, how your body adjusts, and how to get
Free NHS MenB vaccines for eligible students in Kingston, including young people starting university or further education
A guide to erectile dysfunction treatments, how they work, and how to choose the right option for
A guide to what causes erectile dysfunction, what can make it better or worse, and how treatment